References in periodicals archive ?
HINT1 was first described as a protein kinase inhibitor in 1990 [10] and supposed to be protein kinase C inhibitor 1 (PKCI-1) in early literature [11, 12].
Edris et al., "RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling," Cellular Signalling, vol.